Inhibiting programmed cell death to treat a rare childhood disease

Inhibiting programmed cell death to treat a rare childhood disease

A team of researchers at the University of Cologne's Center for Biochemistry, together with the Bambino Gesù Pediatric Hospital in Rome, Italy, have discovered a fundamental biological mechanism that directly connects the immune sensor protein STING to inflammatory cell death.

Blocking Programmed Cell Death: A New Approach to Treating Rare Childhood

In a groundbreaking study recently published in the prestigious journal Nature, a team of scientists from the University of Cologne’s Center for Biochemistry, in partnership with the Bambino Gesù Pediatric Hospital in Rome, has unveiled a crucial, previously unrecognized biological mechanism that links the immune sensing protein STING directly to inflammatory cell death. This pioneering […]